News & Press Releases

ISPE announced that Thomas B. Hartman has been appointed as CEO & President, effective 1 June 2020. Tom has a long history of success in the pharmaceutical industry, rising to the role of Vice President of GMP Operations, Biopharm CMC, for...

ISPE announced featured presenters representing the Food and Drug Administration (FDA) at the 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference. Taking place 1–2 June 2020, this first of its kind fully interactive digital event features...

ISPE announced today the 2020 Facility of the Year Awards (FOYA) Category Winners—including two winners of the inaugural Social Impact Category Award. Awardees include: F. Hoffmann-La Roche Ltd (Equipment Innovation) Pfizer, Inc. (Facility...

Over the last few weeks it has become apparent to the UK committee that our affiliate members have been busy looking at ways they could support the COVID-19 effort. Here are a few items that may be of interest: 3P Innovation - making visors on a not...

ISPE announced today that it has named Jean-François Duliere as a European Regulatory Advisor. Effective 1 April 2020, Duliere takes on this role at ISPE with extensive experience in pharmaceutical regulatory compliance and facilities design for...

Dear fellow members of RMISPE, In the best interest of our members health and safety, the Rocky Mountain ISPE Board of Directors has made the decision to cancel our Spring Educational event on April 16th. At this time, we are not planning on...

ISPE announced Wilson Bryan, MD, Director, Office of Tissues and Advanced Therapies, FDA, as a newly confirmed keynote for the 2020 ISPE Biopharmaceutical Manufacturing Conference, taking place 1–3 June 2020 in Boston, Massachusetts. Wilson Bryan is...

Update 10 April 2020: The search for the new ISPE President and CEO has resumed. At this time, the candidate submission period has closed. The ISPE President and CEO is responsible for providing strategic leadership for the organization by working...

Updated 29 May, 2020 ISPE is closely monitoring the evolution of the Coronavirus situation and we are following the World Health Organization (WHO) guidance and travel advice. Every precaution is being taken to ensure the health and safety of our...

ISPE announced its keynote presenters for the 2020 ISPE Europe Annual Conference. Taking place on 30 March–1 April 2020 in Madrid, Spain, keynote addresses showcase senior-level global pharmaceutical industry leaders offering compelling and...